Multiplikator Forward P/S: Sensus Healthcare (SRTS)
Sensus Healthcare, Inc. (SRTS) leads the development of mobile X-ray systems for combating non-melanoma skin cancer. The expected P/S ratio allows for a real-time assessment of revenue forecasts, while 3.00 expresses the current value of the metric. Sensus Healthcare, Inc. (SRTS) possesses pricing power within its niche, although clinic budgets limit cost growth. Specialized medical logistics ensure system reliability during transportation.
Ringkesan rincian data analitis Sensus (SRTS)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Sensus Healthcare, Inc.|SRTS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Sensus Healthcare, Inc.|SRTS - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Sensus|SRTS - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Sensus Healthcare|Rasio cepet sensushealthcare.com
- rincian asil keuangan lan kelipatan valuasi:
SRTS - Penghasilan resik perusahaan|Bathi sing dikarepake Sensus Healthcare, Inc.|SRTS - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Sensus Healthcare Corp|SRTS - Pangali PEG|Pangali EV/EBITDA Sensus|SRTS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Sensus Healthcare|SRTS - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan sensushealthcare.com|SRTS - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Sensus Healthcare, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:SRTS (Sensus Healthcare)
For an investor in Sensus Healthcare, Inc. (SRTS), the fundamental valuation of the company within the context of its market positioning requires an analysis of expected cash flows. The forward P/S metric correlates market capitalization with projected revenue, allowing an assessment via this curve of how effectively partnerships with oncology clinics to implement radiation therapy systems are converted into the business's market value.
Karo sapa Sensus Healthcare, Inc. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Zynex Corp (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|beyondair.net (XAIR) - Rasio rega marang prakiraan pendapatan|PFSA - Rasio kapitalisasi marang dodolan sing dikarepake|SSKN (STRATA Skin Sciences Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep glucotrack.com GCTK|Rasio rega marang prakiraan pendapatan NanoVibronix (NAOV)|Venus Concept Corporation - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Nuwellis, Inc. NUWE|Rasio kapitalisasi marang dodolan sing dikarepake aethlonmedical.com (AEMD)|ASXC: Multiplikator forward rega marang pendapatan|AVGR - Multiplikator Forward P/S|BioSig Technologies, Inc (BSGM) - Rasio rega marang prakiraan pendapatan|CUTR - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan KNW|NARI: Rega forward marang dodolan|Multiplikator Forward P/S NVRO|RSLS (reshapelifesciences.com) - Rega forward marang dodolan|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
